High Risk MDS or AML Patients
1 clinical trials · Condition
◉ Watch High Risk MDS or AML Patients
| Record | Firm | Date |
|---|---|---|
| Pilot Study to Assess Hematologic Response in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndromes Undergoing Monotherapy With Exjade (Deferasirox) (NCT02233504) | Abramson Cancer Center at Penn Medicine | 2014-08-01 |
Track High Risk MDS or AML Patients automatically
Every clearance here is in the API, with alerts when new ones post.